ArticleTherapeutic advances in neurological disorders2023

First-in-human clinical trial of the NKT cell-stimulatory glycolipid OCH in multiple sclerosis.

Wakiro Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.